Topic: Discovery of ImmunoOncology Therapies: Antibody and Virus-based Approaches (4:00pm – 5:00pm) Aleksandra Filipovic is therapeutic lead for oncology at PureTech. Previously, she was associate medical director, oncology and immuno-oncology, at Bristol Myers Squibb. Dr Filipovic graduated from the Faculty of Medicine University of Nis, Serbia, and did her PhD on identification and validation of therapeutic targets in breast cancer and monoclonal antibody drug development at Imperial College, followed by a Clinical Research Fellowship to continue research and specialty training in medical oncology. She is a clinician at Imperial College NHS trust, European School of Oncology faculty member, associate editor for Frontiers in Oncology, scientific committee member of Sharing Progress in Cancer Care (SPCC) and a member of ASCO, ESMO, AACR and SITC.